Axogen Q2 revenue $34.5M (+3% YoY); adjusted net loss narrows to $2.6M; reaffirms FY2022 guidance

Axogen, Inc.

2022-Q2 EPS reported -$0.46 revenue$65,461,000

Net revenue $34.5M, +3% YoY; ex-Avive (suspended June 2021) revenue grew 9%.
Gross margin 81.8% vs 78.9% in Q2 2021 (included $1.4M Avive write-down).
Adjusted net loss $2.6M ($0.06/share) vs loss $3.7M ($0.09/share) in Q2 2021.
Cash+investments $64.3M, down from $73.7M at March 2022; $3.9M capex for Dayton facility.
FY2022 revenue guidance reaffirmed at $135-142M; gross margin expected above 80%.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.